June 26, 2026 — Jinhe Biotechnology Co., Ltd. said its board voted 9-0 to
approve investment in a flexible production project with annual capacity of
10,000 tons of gramicidin and 20,000 tons of coenzyme Q10 intermediates.
Total investment is about RMB 549.57 million, to be funded by the company’s own
funds or self-raised financing.